Fraser Emma E, Ogden Kathryn J, Radford Andrea, Ingram Emily R, Campbell Joanne E, Dennis Amanda, Corbould Anne M
Department of Psychiatry, Austin Hospital, Heidelberg, Australia.
School of Medicine, Faculty of Health, University of Tasmania, Launceston, Australia.
Health Psychol Behav Med. 2023 Jan 27;11(1):2170378. doi: 10.1080/21642850.2023.2170378. eCollection 2023.
Gestational diabetes mellitus (GDM) complicates ∼16% of pregnancies in Australia and has significant implications for health of both mother and baby. Antenatal anxiety and depression are also associated with adverse pregnancy outcomes. The interaction between GDM and mental health in pregnancy is poorly understood. With the aim of exploring the nuanced interaction between GDM and mental health further, we investigated whether GDM treatment modality (diet versus insulin) influenced psychological wellbeing in women with GDM.
Psychological wellbeing was assessed in women with GDM treated with diet (GDM-Diet, = 20) or insulin (GDM-Insulin, = 15) and pregnant women without GDM (non-GDM, = 20) using questionnaires [Edinburgh Depression Scale (EDS), State-Trait Anxiety Inventory (STAI-6), and in women with GDM, Problem Areas in Diabetes (PAID)] at 24-34 weeks gestation and again at ∼36 weeks gestation.
Women in the GDM-insulin group had significantly higher levels of anxiety than the non-GDM group at both time points. Women in the GDM-Diet group had higher levels of anxiety at 24-34 weeks gestation than the non-GDM group but did not differ at ∼36 weeks gestation. Although depression scores tended to be higher in GDM-Insulin and GDM-Diet groups than in the non-GDM group at both time points, this was not statistically significant. Diabetes-related distress was similar in the GDM-Diet and GDM-Insulin groups at both time points and did not change during pregnancy. A high proportion of the GDM-Insulin group had past/current mental illness (60%).
In this pilot study GDM was associated with differences in psychological wellbeing, specifically increased anxiety in women treated with insulin. Specialised interventions to support women with GDM should be considered, especially those requiring insulin. Not applicable as this was a purely observational study.
妊娠期糖尿病(GDM)使澳大利亚约16%的妊娠复杂化,对母婴健康都有重大影响。产前焦虑和抑郁也与不良妊娠结局相关。妊娠期GDM与心理健康之间的相互作用尚不清楚。为了进一步探索GDM与心理健康之间的细微相互作用,我们调查了GDM治疗方式(饮食与胰岛素)是否会影响GDM女性的心理健康。
使用问卷[爱丁堡抑郁量表(EDS)、状态-特质焦虑量表(STAI-6),以及在GDM女性中使用糖尿病问题领域(PAID)]在妊娠24 - 34周和妊娠约36周时对接受饮食治疗的GDM女性(GDM-饮食组,n = 20)、接受胰岛素治疗的GDM女性(GDM-胰岛素组,n = 15)和无GDM的孕妇(非GDM组,n = 20)进行心理健康评估。
在两个时间点,GDM-胰岛素组女性的焦虑水平均显著高于非GDM组。GDM-饮食组女性在妊娠24 - 34周时的焦虑水平高于非GDM组,但在妊娠约36周时无差异。尽管在两个时间点,GDM-胰岛素组和GDM-饮食组的抑郁评分均倾向于高于非GDM组,但差异无统计学意义。在两个时间点,GDM-饮食组和GDM-胰岛素组的糖尿病相关困扰相似,且在孕期未发生变化。GDM-胰岛素组中有很大比例的女性有过去/当前精神疾病(60%)。
在这项初步研究中,GDM与心理健康差异相关,特别是接受胰岛素治疗的女性焦虑增加。应考虑采取专门干预措施来支持GDM女性,尤其是那些需要胰岛素治疗的女性。由于这是一项纯观察性研究,故不适用。